Pediatrix Medical Group, Inc. MD is strategically positioned to grow on the back of delivering high-quality, evidence-based care in the healthcare space. The company has gained 5.6% in the ...

Pediatrix® Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced the publication of new research on probiotic use and necrotizing enterocolitis (NEC) in preterm ...

Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Pediatrix Medical Group, Inc. MD is a physician services provider company that offers a range of services across various specialties, including newborn care, maternal-fetal, radiology, pediatric ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the healthcare providers & ...

Mark Ordan, Chief Executive Officer, highlighted strong Q4 results with adjusted EBITDA of $66 million, consistent with upwardly adjusted guidance, and cited strong volume, acuity, and payer mix as ...

In its fourth quarter, Pediatrix's revenue came in at nearly $493.8 million, down almost 2% year over year. Net income not in accordance with generally accepted accounting principles (GAAP) also ...